Navigation Links
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Date:5/15/2013

tyrosine kinases shown to aid in the regulation of angiogenesis: fibroblast growth factor (FGF) receptor, platelet-derived growth factor (PDGF) receptor, and vascular endothelial growth factor (VEGF) receptor.

Nintedanib is being evaluated in various solid tumors – including advanced NSCLC, ovarian cancer, liver cancer (hepatic cell carcinoma), kidney cancer (renal cell carcinoma) and colorectal cancer. The advanced NSCLC and ovarian cancer clinical trials are in Phase III development. Nintedanib is also being investigated in Phase III trials for the treatment of Idiopathic Pulmonary Fibrosis (IPF), a progressive and severely debilitating lung disease.

Nintedanib is not approved by the FDA; its safety and efficacy have not been established. 

About Boehringer Ingelheim in Oncology

Building on scientific expertise and excellence in the fields of pulmonary and cardiovascular medicine, metabolic disease, neurology, virology and immunology, Boehringer Ingelheim has embarked on a major research program to discover and develop innovative cancer treatments.  Working in close collaboration with the international scientific community and a number of the world's leading cancer centers, Boehringer Ingelheim's commitment to oncology is underpinned by using advances in science to develop a range of targeted therapies for various solid tumors and hematological cancers. The current focus of late-stage research includes compounds in three areas: signal transduction inhibition, angiogenesis inhibition and cell-cycle kinase inhibition. The company is also evaluating a robust and growing pipeline of early-stage oncology compounds in areas including growth/survival signaling, immunotherapy and epigenetics.

For information about participating in a Boehringer Ingelheim clinical trial, please visit www.bicancertrials.com or call 1.866.725.7110. Healthcare providers interested in learning more
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board ... Officer announced that Tamas Feitel has joined ... joins Numotion after a highly successful 18 year career ... roles driving strategy, profitability, and productivity to result in ... recent position was Chief Financial Officer for GE Healthcare ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... its acquisition of assets related to the ion channel ... that had previously been obtained as part of Pfizer,s ... all of Pfizer,s rights to the "Icagen" name and ... will provide comprehensive services for ion channel and transporter ...
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... BehaviorCorp as medical director in 1990, Dr, Jerry Sheward, ... medical records (EMR) to enable the multi-location behavior health ... adults and children in the Indianapolis area and across ... apart from residing on a reliable but closed operating ...
... 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... interactive website, www.solosendoscopy.com on Friday July 1, ... for existing and new customers and includes comprehensive information ... look showcases streamlined navigation to allow for easy-to-use functionality, ...
Cached Medicine Technology:Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 2Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 3Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 4Solos Endoscopy, Inc. To Launch New Corporate Website 2
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected ... how they interact with products in their everyday lives. Technology can now help homeowners ... to home entertainment and safety, as well as making kitchen tasks simpler. ...
(Date:7/2/2015)... ... , ... no secret that what we consume can have an effect on the body. And during the ... or perhaps even undernourished if not eating enough of the right foods, as well as drinking ... of year to overdo it on the food front as well, with sweet treats like ice ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... California Department of State Hospitals. Prior to using Winscribe’s dictation and clinical documentation ... dictation system to manage their organization’s dictation and transcription processes. , ...
(Date:7/2/2015)... Chicago (PRWEB) , ... July 02, 2015 , ... ... companies innovate across their products, services, channels and business models. To help manage ... is announcing the addition of Mark Benkendorf as SVP of Strategic Engagements. , ...
(Date:7/1/2015)... Livonia, Mich. (PRWEB) , ... July 01, 2015 ... ... the transition of Catholic sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., ... "With the closing today, we have gained an admirable and important partner committed ...
Breaking Medicine News(10 mins):Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4
... sideline even the best athletes, but a new study ... indicates that the use of minimally invasive arthroscopic surgery ... athletes who undergo the procedure another opportunity to resume ... , The researchers at Rush determined that 78 percent ...
... Gardner HealthDay Reporter , SUNDAY, July 18 ... participate in clinical trials for HIV vaccines end up ... they,re not actually infected, a new study shows. ... (VISP), meaning that they possess immune system antibodies to ...
... Sayadi and Joel Herskowitz. They are a wife-husband team ... problems are everywhere and they can be deadly., "Many ... the elderly," said Sayadi, a speech-language pathologist with the Natick ... many things to prevent falls. But not many people realize ...
... of Technology not only involves its students in research, ... innovations. An example of recently licensed university technology is ... in the laboratory. Associate Professor Nasri Nesnas was ... a commonly used laboratory research tool. Most often, neuroscientists ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, July ... panel recommended that the controversial diabetes drug Avandia stay on ... organizations are urging patients not to change their medications before ... use of Avandia to drop off markedly, however. "Why ...
... prey, chemical signals called kairomones serve as an early-warning ... detected by their prey, and can even trigger adaptations, ... help protect the prey. But as widespread as kairomones ... remained largely unknown. New research by Rockefeller University,s Joel ...
Cached Medicine News:Health News:New study finds arthroscopic hip surgery may fully restore function in athletes 2Health News:Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials 2Health News:Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials 3Health News:Swallowing safely is no choke 2Health News:Diabetics Urged to Confer With Their Doctor About Avandia Use 2Health News:Diabetics Urged to Confer With Their Doctor About Avandia Use 3Health News:Scientists identify nature's insect repellents 2
... Digital Flexible Ureteroscope (DUR-D) incorporates many ... proven durable, market leading DUR® series ... first device utilizing Gyrus ACMIs proprietary, ... Metal Oxide Semi-Conductor (CMOS) distal sensor ...
... is the first one-step 20 minutes rapid test ... 2 produced by Enterohemorrhagic Escherichia coli in human ... enrichment of fecal specimens and detects all Toxigenic ... separate result for Toxin 1 and 2 is ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: